Labshake search
Citations for Tocris :
101 - 150 of 2299 citations for 6H Dibenzo b d pyran 3 pentanaminium 6a 7 10 10a tetrahydro 1 hydroxy N N N 6 6 9 hexamethyl 6aR trans 9CI since 2019
Citations are collected from bioRxiv only, the total number of publications could be much larger.
-
bioRxiv - Neuroscience 2020Quote: ... 10 μM 2,3-Dioxo-6-nitro-1,2,3,4-tetrahydrobenzo[f]quinoxaline-7-sulfonamide (NBQX) (Tocris). Each epoch of the BQA experiment contains a stable segment of 28 up to 42 unitary IPSCs (mean 32.75 ± 4.15) ...
-
bioRxiv - Neuroscience 2020Quote: ... 10 μM 2,3-Dioxo-6-nitro-1,2,3,4-tetrahydrobenzo[f]quinoxaline-7-sulfonamide (NBQX) (Tocris), 10 μM 4-(N-Ethyl-N-phenylamino)-1,2 dimethyl-6-(methylamino ...
-
bioRxiv - Neuroscience 2020Quote: ... 40 μM SB431542 (Tocris Bioscience, Bristol, UK, Cat N° 1614) and 3 μM CHIR99021 (Tocris Bioscience ...
-
bioRxiv - Neuroscience 2021Quote: ... 420 μM N-(2,6 Dimethylphenylcarbamoylmethyl) triethylammonium chloride (QX-314; Tocris) was added to the intracellular solution in the patch pipette ...
-
bioRxiv - Neuroscience 2021Quote: ... and Clozapine N-oxide (CNO) dihydrochloride (Tocris Bioscience, Bristol, UK) were used ...
-
bioRxiv - Physiology 2021Quote: ... with clozapine-N-oxide (CNO) (Tocris Bio-techne, Abingdon, UK), in the presence of acute TMT-exposure or restraint stress ...
-
bioRxiv - Neuroscience 2022Quote: Clozapine-N-oxide (CNO; 1.0 mg/kg) (Tocris, Bristol, UK), dissolved in 0.25% dimethyl sulfoxide or 0.9% sterile saline vehicle solution ...
-
bioRxiv - Neuroscience 2023Quote: ... clozapine-N-oxide (CNO) (Tocris,#6329, 5mg/kg 10mL/kg) injection before daily training sessions until the last day of the TC-FR4 training ...
-
bioRxiv - Neuroscience 2023Quote: ... injection of clozapine N-oxide (CNO dihydrochloride, 1 mg/kg, Tocris cat. no. 4936), the ligand that activates hM4Di ...
-
bioRxiv - Neuroscience 2020Quote: ... and N,N,H,-Trimethyl-5-[(tricyclo[3.3.1.13,7]dec-1-ylmethyl)amino]-1-pentanaminiumbromide hydrobromide (IEM-1460, Tocris) were prepared as 10 mM stocks dissolved in distilled water ...
-
bioRxiv - Cell Biology 2019Quote: ... 10µM 6-cyano-7-nitroquinoxaline-2,3-dione (CNQX; Tocris), and 50µM D-(-)-2-amino-5-phosphonopentanoic (D-AP5 or APV ...
-
bioRxiv - Neuroscience 2020Quote: ... Scopolamine hydrobromide and Clozapine-N-oxide (CNO) were purchased from Tocris Biosciences ...
-
bioRxiv - Neuroscience 2023Quote: ... and Clozapine N-oxide dihydrochloride (CNO, 5 mg/kg, Tocris Bioscence) were dissolved in sterile 0.9% NaCl (saline) ...
-
bioRxiv - Neuroscience 2022Quote: ... mice received an injection of Clozapine N-oxide (CNO; Tocris, USA, 1 mg/kg, i.p.), 30 minutes after drug administration they underwent the same procedures ...
-
bioRxiv - Neuroscience 2024Quote: ... injected mice were administered intraperitoneally with Clozapine N-oxide dihydrochloride (CNO, 2mg kg-1, Tocris) ten minutes before the licking or tail shocking task ...
-
bioRxiv - Neuroscience 2023Quote: Pharmacological inhibition of AQP4 was achieved using TGN-020 (N-1,3,4-thiadiazol-2-yl-3-pyridinecarboxamide, Tocris Bioscience, UK). Unless otherwise stated ...
-
bioRxiv - Neuroscience 2020Quote: ... N-methyl D-aspartate (NMDA) receptors were blocked by the non-competitive NMDA receptor antagonist MK-801 (Tocris; 100 μM), co-applied with the competitive α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid AMPA/kainate receptor antagonist CNQX (Tocris ...
-
bioRxiv - Cell Biology 2022Quote: ... 3 µM or 6 µM proTAME (Tocris) and mounted in modified rose chambers ...
-
bioRxiv - Cell Biology 2022Quote: ... 3 µM or 6 µM proTAME (Tocris). For monastrol arrest and release experiments ...
-
bioRxiv - Cell Biology 2022Quote: ... 3 µM or 6 µM proTAME (Tocris).
-
bioRxiv - Neuroscience 2023Quote: ... or 6-Cyano-7-nitroquinoxaline-2,3-dione disodium (CNQX, 10 μM dissolved in H2O; Tocris Bioscience), or tetrodotoxin (TTX ...
-
bioRxiv - Neuroscience 2023Quote: ... either alone or with 10 µM 2,3-Dioxo-6-nitro-1,2,3,4-tetrahydrobenzo[f]quinoxaline-7-sulfonamide (NBQX, Tocris). Neurons were fixed with 4% PFA and 4% sucrose in PBS for 10 minutes at room temperature ...
-
bioRxiv - Neuroscience 2022Quote: ... 6-cyano-7-nitroquinoxaline-2,3-dione (CNQX, TOCRIS bioscience #0190), D,L-2-amino-5-phosphonovaleric acid (AP5 ...
-
bioRxiv - Neuroscience 2020Quote: NNC-711 (1,2,5,6-Tetrahydro-1-[2-[[(diphenylmethylene)amino]oxy]ethyl]-3-pyridinecarboxylic acid hydrochloride) from Tocris
-
bioRxiv - Immunology 2019Quote: ... mice were treated with Clozapine-N-Oxide (CNO, 1mg/Kg intraperitoneally, TOCRIS) each 12h ...
-
bioRxiv - Neuroscience 2020Quote: ... clozapine-N-oxide (CNO, 0.3 mg/kg, ip, cat. number 4936, Tocris). Expression was verified post hoc in all animals ...
-
bioRxiv - Neuroscience 2022Quote: ... stock solution of Clozapine-N-oxide (CNO) (Tocris Bio-techne, Abingdon, UK) was made by dissolving 5 mg of CNO in 1 ml of 0.9% sterile saline solution and stored at 4 °C ...
-
Development of a genetically-encoded sensor for probing endogenous nociceptin opioid peptide releasebioRxiv - Neuroscience 2023Quote: ... To investigate the responses of NOPLight to N/OFQ (cat# 0910, Tocris), increasing concentrations (5 nM ...
-
bioRxiv - Neuroscience 2023Quote: ... the selective hM3Dq agonist clozapine-N-oxide (CNO, Tocris Bioscience, Abingdon, UK) was intraperitoneally injected at a dose of 5 mg/kg ...
-
bioRxiv - Neuroscience 2022Quote: ... animals were treated with the selective positive allosteric modulator (PAM) of mGluR5 3-cyano-N-(1,3-diphenyl-1H-pyrazol-5-yl)benzamide (CDPPB; Tocris, UK) that was diluted in saline solution containing 5-10% final concentration of DMSO and polyethylene glycol 400 (DMSO ...
-
bioRxiv - Neuroscience 2023Quote: ... to block Na channels or 6-Cyano-7-nitroquinoxaline-2,3-dione (CNQX, 10 µM, Tocris, Minneapolis, USA) to block AMPA/kainate receptors were introduced to the standard ACSF.
-
bioRxiv - Neuroscience 2023Quote: ... The [11C]MeOTf was slowly bubbled into a reaction vial containing 0.2mg 11-(1-Piperazinyl)-5H-dibenzo[b,e][1,4]diazepine precursor (Tocris, Bio-Techne Corp., Minneapolis, MN) and 0.3mL anhydrous MeCN (ThermoFisher Scientific ...
-
bioRxiv - Cancer Biology 2022Quote: ... the small molecule 3-[2-[(4-Fluorophenyl)methyl]imidazo[2,1-b]thiazol-6-yl]-2H-1-benzopyran-2-one (iMDK; TOCRIS Bio-techne, 9mg/kg), rapamycin (Sirolimus A8167 ...
-
bioRxiv - Cell Biology 2021Quote: ... 20 μM 6-cyano-7-nitroquinoxaline-2,3-dione (CNQX, Tocris Bioscience) and 50 μM D ...
-
bioRxiv - Neuroscience 2019Quote: ... 50µM 6-Cyano-7-nitroquinoxaline-2,3-dione disodium salt (CNQX, Tocris), 200µM D-(-)-2-Amino-5-phosphonopentanoic acid (D-AP5 ...
-
bioRxiv - Cell Biology 2020Quote: ... and diabetic NOD mice (14-26 weeks; n=3) were intra-peritoneally injected with 50mg/kg of Chloroquine diphosphate (Tocris #4109). Two hours post injection ...
-
bioRxiv - Neuroscience 2023Quote: ... 3-Chloro-4-fluoro-N-[4-[[2-(phenylcarbonyl) hydrazino]carbonyl]benzyl]benzene-sulfonamide (TCN 201, 3 μM dissolved in DMSO; Tocris Bioscience), (αR,βS)-α-(4-Hydroxyphenyl)-β-methyl-4-(phenylmethyl)-1-piperidinepropanol maleate (Ro25-6981 ...
-
bioRxiv - Neuroscience 2023Quote: ... either saline (0.4%) or clozapine N-oxide (CNO, TOCRIS Bioscience, 2 mg/kg) was injected i.p ...
-
bioRxiv - Neuroscience 2019Quote: ... and NMDAR EPSCs were then isolated by addition of the AMPAR antagonist 2,3-Dioxo-6-nitro-1,2,3,4-tetrahydrobenzo[f]quinoxaline-7-sulfonamide (NBQX, 10 µM; Tocris, Cat# 1044). NMDAR EPSCs were confirmed by addition of the NMDAR antagonist D,L-APV (20 µM ...
-
bioRxiv - Neuroscience 2024Quote: Commercially available (±)-7-hydroxy-DPAT HBr (Tocris; 50 mg, 0.15 mmol) was washed with saturated NaHCO3 aqueous solution and extracted with DCM ...
-
bioRxiv - Neuroscience 2021Quote: ... 6-cyano-7-nitroquinoxaline-2,3-dione (CNQX disodium salt, Catalog #1045, Tocris), (R)-Baclofen (Catalog #0796 ...
-
bioRxiv - Neuroscience 2019Quote: ... 20 µM 7-nitro-2,3-dioxo-1,4-dihydroquinoxaline-6-carbonitrile (CNQX; Tocris), and 50 µM D-2-amino-5-phosphonovaleric acid (D-AP-5 ...
-
bioRxiv - Cell Biology 2021Quote: ... at 50 μM and 6-cyano-7-nitroquinoxaline-2,3-dione (CNQX, Tocris) at 20 μM in the bath solution to block excitatory synaptic transmission ...
-
bioRxiv - Neuroscience 2020Quote: ... and CNQX (6-cyano-7-nitroquinoxaline-2,3-dione) were purchased from TOCRIS Bioscience (Cat ...
-
bioRxiv - Neuroscience 2022Quote: ... 2,3-dioxo-6-nitro-7-sulfamoyl-benzoquinoxaline (NBQX, 25 μM; Tocris #0373), D-2-Amino-5-phosphonopentanoic acid (D-AP5 ...
-
bioRxiv - Immunology 2022Quote: ... BV-6 and Birinapant (from SelleckChem) and (5Z)-7-Oxozeaenol (from Tocris) were dissolved in DMSO at 10 mM and added to achieve the final concentrations indicated in figure legends ...
-
bioRxiv - Neuroscience 2022Quote: ... 6-cyano-7-nitroquinoxaline-2,3-dione disodium (CNQX, Tocris, Minneapolis, MN, USA) and d-(−)-2-amino-5-phosphonopentanoic acid (APV ...
-
bioRxiv - Cell Biology 2020Quote: ... The skeletal muscle myosin II inhibitor N-benzyl-p-toluene sulphonamide (BTS, Tocris 1870) was added to fiber dishes at a concentration of 15 μM to reduce Ca2+ induced contraction after plasma membrane injury ...
-
bioRxiv - Neuroscience 2019Quote: ... mice were given 5mg/kg clozapine-n-oxide (CNO; Tocris Biosciences, Cat. No: 4936).
-
bioRxiv - Neuroscience 2021Quote: ... saline or CNO (5 mg/kg, Clozapine N-oxide dihydrochloride, Tocris, Cat. No. 6329) was injected intraperitoneally (i.p. ...